Reasons why post-trial access to trial drugs should, or need not be ensured to research participants: A systematic review

Public Health Ethics

Volumn 4, Issue 2, 2011, Pages 160-184

  Sofaer, Neema ^a   Strech, Daniel ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL (TOPIC); COST; DATA BASE; DECISION MAKING; DRUG LEGISLATION; DRUG SCREENING; FEASIBILITY STUDY; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; LEGAL ASPECT; MEDICAL ETHICS; MEDICAL RESEARCH; PRIORITY JOURNAL; PUBLICATION; REVIEW; SYSTEMATIC REVIEW;

EID: 79960485257     PISSN: 17549973     EISSN: 17549981     Source Type: Journal    
DOI: 10.1093/phe/phr013     Document Type: Review

References (93)

1. 45CFR46 revised (2009). Code of federal regulations title 45
2. Public welfare. Department of health and human services. National Institutes of Health Office for Protection from Research Risks. 45.
3. Annas, G. J. and Grodin, M. A. (1998). Human Rights and Maternal-Fetal HIV Transmission Prevention Trials in Africa. American Journal of Public Health, 88, 560-563. (Pubitemid 28350031)
4. Ashcroft, R. (2005). After the Trial is Over: What are the Sponsor's Obligations? http://www.scidev.net/ en/policy-briefs/after-the-trial-is-over- what-are-the- sponsor-s-obl.html [accessed 27 May 2011].
5. Ballantyne, A. (2005). HIV International Clinical Research: Exploitation and Risk. Bioethics, 19, 476-491. (Pubitemid 41527504)
6. Ballantyne, A. J. (2006a). Exploitation in HIV/AIDS International Clinical Research. PhD Dissertation, Monash University.
7. Ballantyne, A. J. (2006b). Exploitation in HIV/AIDS International Clinical Research. PhD Dissertation, Monash University.
8. Basu, S., Andrews, J. and Smith-Rohrberg, D. (2006). Populations Who Test Drugs Should Benefit from them. Nature, 440, 605.
9. BBC Staff. (2007). Trial Volunteers 'Left in the Lurch'. BBC News Online, 24 December.
10. Benatar, S. R. (2000). Justice and International Research: A Response to Reidar K. Lie. In Levine, R. J. and Gorovitz, S. (eds), Biomedical Research Ethics: Updating International Guidelines. A Consultation, pp. 41-50.
11. Benatar, S. R. and Fleischer, T. E. (2007). Ethical Issues in Research in Low-Income Countries. The International Journal of Tuberculosis and Lung Disease, 11, 617-623. (Pubitemid 46868621)
12. Berkley, S. (2003). Thorny Issues in the Ethics of AIDS Vaccine Trials. Lancet, 362, 992. (Pubitemid 37159298)
13. Brody, B. A. (2002). Ethical Issues in Clinical Trials in Developing Countries. Statistics in Medicine, 21, 2853-2858.
14. Busse, P. (1997). Strident, but Essential: The Voices of People with AIDS. British Medical Journal, 314, 888-889. (Pubitemid 27182027)
15. Carse, A. L. and Little, M. O. (2008). Exploitation and the Enterprise of Medical Research. In Hawkins, J. S. and Emanuel, E. J. (eds), Exploitation and Developing Countries: The Ethics of Clinical Research. Princeton and Oxford: Princeton University Press, pp. 206-245.
16. Chang, E. (2002). Fitting a Square Peg into a Round Hole? Imposing Informed Consent and Post-Trial Obligations on United States Sponsored Clinical Trials in Developing Countries. Southern California Interdisciplinary Law Journal, 11, 339-360.
17. Ciaranello, A. L., Walensky, R. P., Sax, P. E., Chang, Y., Freedberg, K. A. and Weissman, J. S. (2009). Access to Medications and Medical Care after Participation in HIV Clinical Trials: A Systematic Review of Trial Protocols and Informed Consent Documents. HIV Clinical Trials, 10, 13-24
18. CIOMS. (1982). Proposed International Guidelines for Biomedical Research Involving Human Subjects. Geneva: World Health Organization and Council for International Organizations of Medical Sciences.
19. CIOMS. (1983). International Ethical Guidelines for Biomedical Research Involving Human Subjects. Proposed Guidelines. Geneva: CIOMS (Council for International Organisations of Medical Sciences) and WHO (World Health Organization).
20. CIOMS. (1991). International Guidelines for Ethical Review of Epidemiological Studies. Geneva: Council of International Organizations of Medical Sciences (CIOMS).
21. CIOMS. (1993). International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva: Council for International Organizations of Medical Sciences.
22. CIOMS. (2002). International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva: Council for International Organizations of Medical Sciences.
23. Cleaton-Jones, P. E. (1997). An Ethical Dilemma. Availability of Antiretroviral Therapy After Clinical Trials with HIV Infected Patients are Ended. British Medical Journal, 314, 887-888. (Pubitemid 27182026)
24. Cohen, E., O'Neill, J., Joffres, M., Upshur, R. and Mills, E. (2008). Reporting of Informed Consent, Standard of Care and Post-Trial Obligations in Global Randomized Intervention Trials: A Systematic Survey of Registered Trials. Developing World Bioethics, 9, 74-80.
25. Cooley, D. R. (2001). Distributive Justice and Clinical Trials in the Third World. Theoretical Medicine and Bioethics, 22, 151-167. (Pubitemid 32674242)
26. Crouch, R. A. and Arras, J. D. (1998). Azt Trials and Tribulations. Hastings Center Report, 28, 26-34. (Pubitemid 128746714)
27. Daniels, N. (2008). Just Health: Meeting Health Needs Fairly. Cambridge; New York: Cambridge University Press.
28. Dworkin, R. (2000). Sovereign Virtue: The Theory and Practice of Equality. Cambridge, MA: Harvard University Press.
29. Emanuel, E. J. (1998). A World of Research Subjects. Hastings Center Report, 28, 25.
30. Emanuel, E. J. (2008). Benefits to Host Countries. In Emanuel, E. J., Grady, C., Crouch, R. A., Lie, R. K., Miller, F. G. and Wendler, D. (eds), The Oxford Textbook of Clinical Research Ethics. Princeton; Oxford: Princeton University Press, pp. 719-728.
31. Emanuel, E. J., Grady, C., Crouch, R. A., Lie, R. K., Miller, F. G. and Wendler, D. (2008). Introduction. In Emanuel, E. J., Grady, C., Crouch, R. A., Lie, R. K., Miller, F. G. and Wendler, D. (eds), The Oxford Textbook of Clinical Research Ethics. New York: Oxford University Press, pp. 3-6.
32. Fernandez, C. V., Kodish, E. and Weijer, C. (2003). Informing Study Participants of Research Results: An Ethical Imperative. IRB: Ethics and Human Research, 25, 12-19.
33. Gbadegesin, S. and Wendler, D. (2006). Protecting Communities in Health Research from Exploitation. Bioethics, 20, 248-253. (Pubitemid 44199391)
34. Glantz, L. H., Annas, G. J., Grodin, M. A. and Mariner, W. K. (1998). Research in Developing Countries: Taking "Benefit" Seriously. Hastings Center Report, 28, 38-42. (Pubitemid 128746716)
35. Gostin, L. (1991). Ethical Principles for the Conduct of Human Subject Research: Population-based Research and Ethics. Law, Medicine and Health Care, 19, 191-201.
36. Grady, C. (2005). The Challenge of Assuring Continued Post-Trial Access to Beneficial Treatment. Yale Journal of Health Policy, Law, and Ethics, 5, 425-435.
37. Greenhalgh, T. and Peacock, R. (2005). Effectiveness and Efficiency of Search Methods in Systematic Reviews of Complex Evidence: Audit of Primary Sources. British Medical Journal, 331, 1064-1065. (Pubitemid 41597859)
38. Greenwood, B. and Hausdorff W. P. (2003). After a Trial is Over: The Ethical Issues [Internet]. Available from: http://www.scidev.net/en/policy- briefs/after-a-trial-is-over-the-ethical-issues-1.html [accessed 27 May 2011].
39. Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P. and Schunemann, H. J. (2008). Grade: An Emerging Consensus on Rating Quality of Evidence and Strength of Recommendations. British Medical Journal, 336, 924-926. (Pubitemid 351632017)
40. Harth, S. C. and Thong, Y. H. (1995). Aftercare for Participants in Clinical Research: Ethical Considerations in an Asthma Drug Trial. Journal of Medical Ethics, 21, 225-228.
41. Hawkins, J. S. and Emanuel, E. J. (2008). Introduction: Why exploitation? In Hawkins, J. S. and Emanuel, E. J. (eds), Exploitation and Developing Countries: The Ethics of Clinical Research. Princeton; Oxford: Princeton University Press, pp. 1-20.
42. Hutt, L. E. (1998). Freebies for Subject 641: A Discussion of the Ethical Prospect of Providing Drug Trial Subjects with Post-Trial Access to the Drug Tested-A Canadian Perspective. Health Law Journal, 6, 169-187.
43. India Council of Medical Research. (2006). Ethical Guidelines for Biomedical Research on Human Participants. New Delhi: Indian Council of Medical Research.
44. Kass, N. and Hyder, A. (2002). Attitudes and Experiences of U.S. and Developing Country Investigators Regarding U.S. HUMAN Subjects Regulations. In National Bioethics Advisory Commission Group (ed.) Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries II: Commissioned Papers. Bethesda, MD: National Bioethics Advisory Commission, pp. B1-B220.
45. King, P. (1997). A Partnership to Resolve the Conundrum. British Medical Journal, 314, 890-891. (Pubitemid 27182030)
46. Kolata, G. and Eichenwald, K. (1999). Stopgap Medicine, a Special Report: For the Uninsured, Drug Trials are Health Care. New York Times, 22 June.
47. Kottow, M. H. (2002). Who is My Brother's Keeper? Journal of Medical Ethics, 28, 24-27. (Pubitemid 34162894)
48. Lavery, J. V. (2004). Putting International Research Ethics Guidelines to Work for the Benefit of Developing Countries. Yale Journal of Health Policy, Law and Ethics, 4, 319-336.
49. Lavery, J. V. (2008). The Obligation to Ensure Access to Beneficial Treatments for Research Participants at the Conclusion of Clinical Trials. In Emanuel, E. J., Grady, C., Crouch, R. A., Lie, R. K., Miller, F. G. and Wendler, D. (eds), The Oxford Textbook of Clinical Research Ethics. New York: Oxford University Press, pp. 697-710.
50. Lemmer, B., Grellier, R. and Steven, J. (1999). Systematic Review of Nonrandom and Qualitative Research Literature: Exploring and Uncovering an Evidence Base for Health Visiting and Decision Making. Qualitative Health Research, 9, 315-328.
51. Lie, R. (2000). Justice and International Research. In Levine, R., Gorovitz, S. and Gallagher, J. (eds), Biomedical Research Ethics: Updating International Guidelines. Geneva: CIOMS, pp. 27-40.
52. Lo, B. and Bayer, R. (2003). Establishing Ethical Trials for Treatment and Prevention of AIDS in Developing Countries. British Medical Journal, 327, 337-339. (Pubitemid 36966630)
53. London, A. J. (2005). Justice and the Human Development Approach to International Research. Hastings Center Report, 35, 24-37. (Pubitemid 40712162)
54. Macklin, R. (2004). Double Standards in Medical Research in Developing Countries. Cambridge, UK: Cambridge University Press.
55. Macpherson, C. C. (2004). Research Sponsors Duties to Developing World Host Nations: The Ongoing WMA Discussion of Possible Revisions to the 2000 Declaration of Helsinki (paragraph 30). Developing World Bioethics, 4, 173-175.
56. McCullough, L. B., Coverdale, J. H. and Chervenak, F. A. (2004). Argument-based Medical Ethics: A Formal Tool for Critically Appraising the Normative Medical Ethics Literature. American Journal ofObstetrics and Gynecology, 191, 1097-1102. (Pubitemid 39421557)
57. McCullough, L. B., Coverdale, J. H. and Chervenak, F. A. (2007). Constructing a Systematic Review for Argument-Based Clinical Ethics Literature: The Example of Concealed Medications. Journal of Medicine and Philosophy, 32, 65-76.
58. McLean, G. R. (1997). A Case for Goodwill. British Medical Journal, 314, 890. (Pubitemid 27182029)
59. Merritt, M. (2007). Bioethics, Philosophy and Global Health. Yale Journal of Health Policy, Law, and Ethics, 7, 273-317.
60. Merritt, M. and Grady, C. (2006). Reciprocity and Post-Trial Access for Participants in Antiretroviral Therapy Trials. AIDS, 20, 1791-1794. (Pubitemid 44358896)
61. Millum, J. (2009). Post-trial Access to Antiretrovirals: Who Owes What to Whom? Bioethics [Internet]. Available from: http://onlinelibrary.wiley.com/doi/ 10.1111/j.1467-8519.2009.01736.x/pdf [accessed 7 July 2009].
62. National Bioethics Advisory Commission Group. (2001). Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries. Bethesda, MD: National Bioethics Advisory Commission.
63. NIH Group (2005). Guidance for Addressing the Provision of Antiretroviral Treatment for Trial Participants Following their Completion of NIH-Funded HIV Antiretroviral Treatment Trials in Developing Countries. In National Institutes of Health (ed.).
64. Nuffield Council on Bioethics (2002). The Ethics of Research Related to Healthcare in Developing Countries. London: Nuffield Council on Bioethics.
65. Nuffield Council on Bioethics Group. (1999). TheEthics of Clinical Research in Developing Countries: A Discussion Paper. London: Nuffield Council on Bioethics.
66. Nuffield Council on Bioethics Group. (2002). TheEthics of Research Related to Healthcare in Developing Countries. London: Nuffield Council on Bioethics.
67. Orentlicher, D. (2002). Universality and its Limits: When Research Ethics can Reflect Local Circumstances. The Journal of Law, Medicine and Ethics, 30, 403-410. (Pubitemid 39258073)
68. Pace, C., Miller, F. G. and Danis, M. (2003). Enrolling the Uninsured in Clinical Trials: An Ethical Perspective. Critical CareMedicine, 31, S121-S125. (Pubitemid 36379555)
69. Page, A. K. (2002). Prior Agreements in International Clinical Trials: Ensuring the Benefits of Research to Developing Countries. Yale Journal ofHealth Policy, Law, and Ethics, 3, 35-66.
70. Page, A. K. (2004). Ethical Issues in International Biomedical Research: An Overview. Journal of Health Law, 37, 629-665.
71. Participants in the 2001 Conference on Ethical Aspects ofResearch in Developing Countries. (2004). Moral Standards for Research in Developing Countries: From "reasonable availability" to "fair benefits". Hastings CenterReport, 34, 17-27.
72. Participants in the Conference on Ethical Aspects of Research in Developing Countries. (2002). Ethics. Fair benefits for research in developing countries. Science, 298(5601), 2133-2134.
73. PhRMA Group. (2001). PhRMA Discussion Paper on the Declaration ofHelsinki as Revised in October 2000. Washington, DC, USA: Pharmaceutical Research and Manufacturers of America.
74. Richardson, H. S. (2007). Gradations of Researchers' Obligation to Provide Ancillary Care for HIV/AIDS in Developing Countries. American Journal of Public Health, 97, 1956-1961. (Pubitemid 351194724)
75. Richardson, H. S. and Belsky, L. (2004). The Ancillary-Care Responsibilities of Medical Researchers: An Ethical Framework for Thinking about the Clinical Care that Researchers Owe their Subjects. Hastings Center Report, 34, 25-33.
76. Sachs, B. (2009). Going from Principles to Rules in Research Ethics. Bioethics [Internet]. Available from: http://grants.nih.gov/grants/policy/ antiretroviral/ [accessed 27 May 2011].
77. Shaffer, D. N., Yebei, V. N., Ballidawa, J. B., Sidle, J. E., Greene, J. Y., Meslin, E. M., Kimaiyo, S. J. and Tierney, W. M. (2006). Equitable Treatment for HIV/AIDS Clinical Trial Participants: A focus Group Study of Patients, Clinician Researchers, and Administrators in Western Kenya. Journal of Medical Ethics, 32, 55-60. (Pubitemid 43085477)
78. Shah, S., Elmer, S. and Grady, C. (2009). Planning for Posttrial Access to Antiretroviral Treatment for Research Participants in Developing Countries. American Journal of Public Health, 99, 1556-1562.
79. Siegel, A. W. (2008). Kantian Ethics, Exploitation, and Multinational Clinical Trials. In Hawkins, J. S. and Emanuel, E. J. (eds), Exploitation and Developing Countries: The Ethics of Clinical Research. Princeton; Oxford: Princeton University Press, pp. 286-313.
80. Slack, C., Stobie, M., Milford, C., Lindegger, G., Wassenaar, D., Strode, A. and Ijsselmuiden, C. (2005). Provision of HIV Treatment in HIV Preventive Vaccine Trials: A Developing Country Perspective. Social Science and Medicine, 60, 1197-1208. (Pubitemid 40038752)
81. Sofaer, N. and Strech, D. (2011). The Need for Systematic Reviews of Reasons. Bioethics, doi: 10.1111/j.1467-8519.2011.01858.x (Epub ahead of print 27 April 2011).
82. Sofaer, N., Thiessen, C., Campbell, E. G., Ballou, J., Goold, S. D., Getz, K. A., Koski, G., Krueger, R. A. and Weissman, J. S. (2009). Subjects' Views of Obligations to Ensure Post-Trial Access to Drugs, Care, and Information: Qualitative Results from the Experiences of Participants in Clinical Trials (epic) Study. Journal of Medical Ethics, 35, 183-188.
83. Strech, D., Synofzik, M. and Marckmann, G. (2008). Systematic Reviews of Empirical Bioethics. Journal of Medical Ethics, 34, 472-477.
84. The European Group on Ethics in Science and New Technologies to the European Commission. 2003). Ethical Aspects of Clinical Research in Developing Countries [Internet]. Available from: http;//europa.eu.int/comm/european-group- ethics/ docs/avis17-en.pdf [accessed].
85. UNAIDS Group (2000). Ethical Considerations in HIV Preventive Vaccine Research: UNAIDS Guidance Document.
86. Wellcome Trust Group. (2004). Research Involving People Living in Developing Countries: Position Statement and Guidance Notes for Applicants [Internet]. Available from: http://www.wellcome.ac .uk/About-us/Policy/Policy- and-position-statements/ WTD015295.htm [accessed 27 May 2011].
87. Wertheimer, A. (1999). Exploitation. Princeton, NJ: Princeton University Press.
88. Wertheimer, A. (2008). Exploitation in Clinical Research. In Hawkins, J. S. and Emanuel, E. J. (eds), Exploitation and Developing Countries: The Ethics of Clinical Research. Princeton and Oxford: Princeton University Press, pp. 63-104.
89. Wolinsky, H. (2006). The Battle of Helsinki: Two Troublesome Paragraphs in the Declaration of Helsinki are Causing a Furore Over Medical Research Ethics. EMBO Report, 7, 670-672 (Pubitemid 43986260)
90. World Medical Association. (2004). Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Ferney-Voltaire: World Medical Association.
91. World Medical Association. (2008) World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects [Internet]. Ferney-Voltaire: World Medical Association, available from: http://www.wma. net/en/30publications/10policies/b3/17c.pdf [accessed 27 May 2011].
92. Yearby, R. (2004). Good Enough to Use for Research, but Not Good Enough to Benefit from the Results of that Research: Are the Clinical HIV Vaccine Trials in Africa Unjust? De Paul Law Review, 53, 1127-1154.
93. Zong, Z. (2008). Should Post-Trial Provision of Beneficial Experimental Interventions be Mandatory in Developing Countries? Journal of Medical Ethics, 34, 188-192.